HomeBOLT • NASDAQ
add
Bolt Biotherapeutics Inc
Previous close
$0.31
Year range
$0.28 - $0.78
Market cap
11.71M USD
Avg Volume
529.71K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 1.22M | -76.83% |
Operating expense | 4.14M | -39.23% |
Net income | -11.04M | -2.12% |
Net profit margin | -903.44 | -340.72% |
Earnings per share | -0.29 | -3.57% |
EBITDA | -11.72M | 29.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 38.84M | -57.48% |
Total assets | 85.86M | -39.91% |
Total liabilities | 39.05M | 0.82% |
Total equity | 46.81M | — |
Shares outstanding | 38.34M | — |
Price to book | 0.25 | — |
Return on assets | -32.66% | — |
Return on capital | -39.35% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -11.04M | -2.12% |
Cash from operations | -13.36M | 20.21% |
Cash from investing | 14.55M | 42.61% |
Cash from financing | — | — |
Net change in cash | 1.19M | 118.11% |
Free cash flow | -9.09M | 23.94% |
About
Founded
2015
Headquarters
Website
Employees
52
